Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,738031,Alc14,Alcohol consumption QTL 14,7.6,0.00003,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,58640017,154427984,Rat,n/a,region,qtl 1000,738016,Alc16,Alcohol consumption QTL 16,3.6,0.00015,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,58640017,154427984,Rat,n/a,region,qtl 1000,70200,Alc18,Alcohol consumption QTL 18,9.2,,drinking behavior trait (VT:0001422),ethanol intake volume to total fluid intake volume ratio (CMO:0001591),4,55324953,148360954,Rat,n/a,region,qtl 1000,1641833,Alc21,Alcohol consumption QTL 21,8.6,0.0001,drinking behavior trait (VT:0001422),ethanol drink intake rate (CMO:0001407),4,55375865,125671711,Rat,n/a,region,qtl 1000,1641919,Alc22,Alcohol consumption QTL 22,,0.0005,drinking behavior trait (VT:0001422),ethanol drink intake rate (CMO:0001407),4,62947687,125671711,Rat,n/a,region,qtl 1000,6478684,Anxrr30,Anxiety related response QTL 30,,0.00087,defecation behavior trait (VT:0010462),defecation rate (CMO:0000998),4,63812687,108812687,Rat,n/a,region,qtl 1000,6478743,Anxrr40,Anxiety related response QTL 40,,0.83076,defecation behavior trait (VT:0010462),defecation rate (CMO:0000998),4,63812687,108812687,Rat,n/a,region,qtl 1000,6478772,Anxrr49,Anxiety related response QTL 49,,0.15488,defecation behavior trait (VT:0010462),defecation rate (CMO:0000998),4,63812687,108812687,Rat,n/a,region,qtl 1000,12798520,Anxrr55,Anxiety related response QTL 55,4.45,0.01,locomotor behavior trait (VT:0001392),number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715),4,29549895,112807890,Rat,n/a,region,qtl 1000,2300179,Bmd50,Bone mineral density QTL 50,5.9,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),4,61975371,106975371,Rat,n/a,region,qtl 1000,5685009,Bmd86,Bone mineral density QTL 86,3.7,,tibia mineral mass (VT:1000283),bone mineral density (CMO:0001226),4,55324857,79575658,Rat,n/a,region,qtl 1000,5685012,Bmd87,Bone mineral density QTL 87,5.1,,tibia mineral mass (VT:1000283),bone mineral content (CMO:0001554),4,55324857,79575658,Rat,n/a,region,qtl 1000,631651,Bp124,Blood pressure QTL 124,3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,63938412,108938412,Rat,n/a,region,qtl 1000,724522,Bp146,Blood pressure QTL 146,2.2,0.0021,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,75258970,120258970,Rat,n/a,region,qtl 1000,61336,Bp21,Blood pressure QTL 21,4.6,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,55791834,79557856,Rat,n/a,region,qtl 1000,2303168,Bp330,Blood pressure QTL 330,4.25,0.017,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,3043231,145254791,Rat,n/a,region,qtl 1000,10755501,Bp390,Blood pressure QTL 390,2.5,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),4,23850384,169318094,Rat,n/a,region,qtl 1000,619616,Bp79,Blood pressure QTL 79,,0.0292,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,3043231,79575658,Rat,n/a,region,qtl 1000,631546,Bp86,Blood pressure QTL 86,3.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,55791564,92484312,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),4,61708341,113100992,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,61708341,113100992,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,61708341,113100992,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),percent change in mean arterial blood pressure (CMO:0002035),4,61708341,113100992,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),percent change in systolic blood pressure (CMO:0000747),4,61708341,113100992,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),absolute change in pulse pressure (CMO:0001882),4,61708341,113100992,Rat,n/a,region,qtl 1000,70192,BpQTLcluster5,Blood pressure QTL cluster 5,4.183,,arterial blood pressure trait (VT:2000000),absolute change in mean arterial blood pressure (CMO:0000533),4,61708341,113100992,Rat,n/a,region,qtl 1000,1578657,Bss12,Bone structure and strength QTL 12,8.9,,femur morphology trait (VT:0000559),femoral neck cross-sectional area (CMO:0001697),4,56092756,101092756,Rat,n/a,region,qtl 1000,1578658,Bss13,Bone structure and strength QTL 13,8,,femur strength trait (VT:0010010),femoral neck polar moment of inertia (CMO:0001670),4,56092756,101092756,Rat,n/a,region,qtl 1000,4889969,Bss96,Bone structure and strength QTL 96,4.9,,tibia size trait (VT:0100001),tibia cortical bone volume (CMO:0001725),4,55324857,79575658,Rat,n/a,region,qtl 1000,4889972,Bss97,Bone structure and strength QTL 97,5.6,,tibia size trait (VT:0100001),tibia total bone volume (CMO:0001724),4,55324857,79575658,Rat,n/a,region,qtl 1000,6893678,Bw108,Body weight QTL 108,2.6,0.006,body mass (VT:0001259),body weight (CMO:0000012),4,42415777,87415777,Rat,n/a,region,qtl 1000,7394826,Bw126,Body weight QTL 126,,0.002,body mass (VT:0001259),body weight gain (CMO:0000420),4,61708103,88565113,Rat,n/a,region,qtl 1000,8552801,Bw143,Body weight QTL 143,7.3,,body mass (VT:0001259),ratio of change in body weight to total body weight (CMO:0002216),4,31825560,83531021,Rat,n/a,region,qtl 1000,8694439,Bw168,Body weight QTL 168,9.57,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),4,39208247,84208247,Rat,n/a,region,qtl 1000,1549839,Bw52,Body weight QTL 52,,0.0001,body mass (VT:0001259),body weight gain (CMO:0000420),4,60439127,113416139,Rat,n/a,region,qtl 1000,1549843,Bw53,Body weight QTL 53,,0.0001,body mass (VT:0001259),body weight gain (CMO:0000420),4,60439127,99066957,Rat,n/a,region,qtl 1000,61330,Eau1,Experimental allergic uveoretinitis QTL 1,,0.0003,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),4,70773471,132455556,Rat,n/a,region,qtl 1000,1576305,Emca6,Estrogen-induced mammary cancer QTL 6,5.8,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),4,43414605,155469929,Rat,n/a,region,qtl 1000,1354612,Foco1,Food consumption QTL 1,8.87,,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),4,43414792,146942075,Rat,n/a,region,qtl 1000,2312567,Glom19,Glomerulus QTL 19,1.9,0.006,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),4,49906054,145611886,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,7850904,182171018,Rat,n/a,region,qtl 1000,634344,Hcar7,Hepatocarcinoma resistance QTL 7,7.8,,liver integrity trait (VT:0010547),liver tumorous lesion area to total liver area ratio (CMO:0001075),4,71476518,116476518,Rat,n/a,region,qtl 1000,634344,Hcar7,Hepatocarcinoma resistance QTL 7,7.8,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),4,71476518,116476518,Rat,n/a,region,qtl 1000,1300139,Hrtrt6,Heart rate QTL 6,2.85,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,37703272,115372927,Rat,n/a,region,qtl 1000,631671,Iddm11,Insulin dependent diabetes mellitus QTL 11,3.6,0.0012,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),4,57307075,79578854,Rat,n/a,region,qtl 1000,631674,Iddm14,Insulin dependent diabetes mellitus QTL 14,,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),4,63537179,157286626,Rat,n/a,region,qtl 1000,6909122,Insul22,Insulin level QTL 22,4.63,,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),4,23991721,76238799,Rat,n/a,region,qtl 1000,8655961,Kidm43,Kidney mass QTL 43,18,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),4,34277932,99067150,Rat,n/a,region,qtl 1000,6909128,Pancm4,Pancreatic morphology QTL 4,11.35,,pancreas mass (VT:0010144),pancreas wet weight (CMO:0000626),4,23991721,76238799,Rat,n/a,region,qtl 1000,2302051,Pia28,Pristane induced arthritis QTL 28,5.3,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112),4,75258970,120258970,Rat,n/a,region,qtl 1000,61418,Pia5,Pristane induced arthritis QTL 5,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,61038901,127777403,Rat,n/a,region,qtl 1000,2312569,Pur19,Proteinuria QTL 19,3.4,0.001,total urine protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),4,65989243,97759057,Rat,n/a,region,qtl 1000,8655906,Rf60,Renal function QTL 60,3.8,,blood creatinine amount (VT:0005328),creatinine clearance (CMO:0000765),4,26654749,81874227,Rat,n/a,region,qtl 1000,738009,Sach4,Saccharine consumption QTL 4,4.9,0.000016,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,58640017,154427984,Rat,n/a,region,qtl 1000,634311,Sach7,Saccharin preference QTL 7,,,taste sensitivity trait (VT:0001986),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,55791564,82134186,Rat,n/a,region,qtl 1000,1354660,Salc1,Saline consumption QTL 1,11.26,,drinking behavior trait (VT:0001422),saline drink intake rate (CMO:0001627),4,43414792,146942075,Rat,n/a,region,qtl 1000,1358363,Sradr3,Stress Responsive Adrenal Weight QTL 3,6.19,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),4,58166424,103166424,Rat,n/a,region,qtl 1000,1358352,Srcrt3,Stress Responsive Cort QTL 3,2.29,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,36615599,145611886,Rat,n/a,region,qtl 1000,631646,Stl4,Serum triglyceride level QTL 4,6.5,0.0001,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),4,73786419,132455556,Rat,n/a,region,qtl 1000,1298082,Stresp4,Stress response QTL 4,,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,46898276,145611886,Rat,n/a,region,qtl 1000,61445,Strs3,Sensitivity to stroke QTL 3,3,,cerebrum integrity trait (VT:0010549),post-insult time to onset of cerebrovascular lesion (CMO:0002343),4,39208222,84208222,Rat,n/a,region,qtl 1000,1558651,Swd3,Spike wave discharge measurement QTL 3,4.62,0.000024,brain electrophysiology trait (VT:0010557),brain spike-and-wave discharge frequency (CMO:0001742),4,57101077,92990863,Rat,n/a,region,qtl 1000,631261,Tcas3,Tongue tumor susceptibility QTL 3,6.88,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),4,7342404,92484039,Rat,n/a,region,qtl 1000,8552782,Vie1,Viral induced encephalitis QTL 1,26.4,,brain integrity trait (VT:0010579),encephalitis incidence/prevalence measurement (CMO:0002361),4,31825560,83531021,Rat,n/a,region,qtl 1000,8552807,Vie4,Viral induced encephalitis QTL 4,7.3,,brain integrity trait (VT:0010579),encephalitis incidence/prevalence measurement (CMO:0002361),4,61708341,83531021,Rat,n/a,region,qtl 1000,8552809,Vie5,Viral induced encephalitis QTL 5,25.3,,brain integrity trait (VT:0010579),encephalitis incidence/prevalence measurement (CMO:0002361),4,31825560,83531021,Rat,n/a,region,qtl